Using Walk With Ease Walking Program With Men 65 and Older Being Treated for Prostate Cancer

Purpose: This pilot study evaluates the feasibility of implementing a moderate-intensity
physical activity (PA) program in a sample of men age 65 or older with a prostate cancer
diagnosis undergoing various forms of treatment or active surveillance.

Participants: Men, 65 and older, with a prostate cancer diagnosis.

Procedures (methods): This study will enroll subjects in a 6 week walking program called
Walk with Ease (WWE) and see if walking can be sustained for up to three months. In
addition, the study will perform a Geriatric Assessment and gather preliminary data on
self-reported quality of life outcomes and self-reported physical activity as captured in a
daily walking log.

Inclusion Criteria:

- ≥65 years of age

- Histologically confirmed Stage I, II or III prostate cancer (endocrine (± radiation)
patients may be Stage IV)

- Undergoing prostate cancer treatment (post-surgery only, radiation only, endocrine
therapy (± radiation), or active surveillance)

- English speaking

- IRB approved, signed written informed consent

- Approval from their treating physician to engage in moderate-intensity physical
activity

- Patient-assessed ability to walk and engage in moderate physical activity

- Willing and able to meet all study requirements

Exclusion Criteria:

- One or more significant medical conditions that in the physician's judgment preclude
participation in the walking intervention

- Major surgery scheduled within the study period

- Unable to walk or engage in moderate-intensity physical activity

- Already actively walking (150 minutes per week)